-->

, Don’t Miss My Next Best Trade Idea

Post a Comment


Hello ,



With states rolling back re-opening plans...


It looks as if many of us will still be stuck at home…


And that means more potential traders piling into stocks.


There are a lot of these beginner traders who are just buying randomly…


And not focused on uncovering the best ideas out there.


Well, instead of getting on social media or complaining about how messed up things are…


I've decided to focus on trading—and helping others. 


How?


By teaching them how to develop an edge in the market


In order to make learning how to trade more accessible…


I've decided to lower the price of Fast 5 Trades — my highest conviction trade idea service at its lowest price point ever.


For a limited time only, you can take it for a spin…


Get 8 Weeks Of Fast 5 Trades For $8


I really can't make the deal any sweeter than that.


Take advantage of this exclusive offer now.


Who knows… maybe in the coming days, you'll find success as some traders have had with Fast 5 Trades…*




Don't miss your chance to get Fast 5 Trades: $8 For 8 Weeks Special


Join now. I'll be releasing my next best trade idea on Monday...


Don't miss out.






*Results presented are not typical and may vary from person to person. RagingBull does not

track or verify subscribers' trading results. These individual experiences should not be understood as typical or representative. Please see our full disclaimer here: ragingbull.com/disclaimer.


Special



RagingBull, LLC
62 Calef Hwy. #233, Lee, NH 03861

Click Here to stop receiving emails from kyle@biotechbreakouts.com
Unsubscribe from all RagingBull emails

DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization.

WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication.

If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter